The Quality of Life and its Relationship to Disease Severity in Children with Atopic Dermatitis
Keywords:
Atopic dermatitis, quality of life, SCORAD, CDLQI, childhood eczemaAbstract
Background: Atopic dermatitis (AD) is a common chronic inflammatory skin condition in children, characterized by pruritus, recurrent eczematous lesions, and fluctuating severity. Beyond its dermatological manifestations, AD imposes a significant psychosocial and functional burden on patients and their families. Objective: This study aimed to determine the correlation between quality of life and disease severity among Pakistani children with atopic dermatitis. Methods: This descriptive cross-sectional study was conducted in the Department of Dermatology, Pakistan Airforce (PAF) Hospital, Islamabad, over six months (January–June 2022). Seventy children aged 5–15 years, diagnosed with AD by Hanifin and Rajka criteria, were enrolled. Disease severity was assessed using the Scoring of Atopic Dermatitis (SCORAD) index, and quality of life was measured using the Children’s Dermatology Life Quality Index (CDLQI). Data were analyzed using SPSS version 25, with Pearson’s correlation applied to evaluate relationships between SCORAD and CDLQI scores. Results: The mean age of participants was 10.2±2.8 years . According to SCORAD, 22.9% had mild, 70% moderate, and 7.1% severe disease. The mean SCORAD and CDLQI scores were 25.3 ± 8.0 and 9.8 ± 4.0, respectively. A statistically significant positive correlation was observed between disease severity and quality-of-life impairment (r = 0.289, p = 0.015). Conclusion: Greater disease severity is associated with a higher degree of quality-of-life impairment among Pakistani children with atopic dermatitis. Regular use of standardized tools such as SCORAD and CDLQI can help clinicians identify patients requiring holistic care, including psychological and social support.References
Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, et al. Global prevalence and severity of atopic dermatitis: A systematic rev- iew and meta-analysis. Allergy. 2021;76(3):893–915. https://doi.org/10.1111/all.14618
Odhiambo JA, Williams HC, Clayton TO, Robert- son CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6): 1251–1258.e23.
https://doi.org/10.1016/j.jaci.2009.10.009
Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284–1293.
https://doi.org/10.1111/all.13401
Li AW, Yin ES, Antaya RJ. Environmental factors associated with pediatric atopic dermatitis: An updated review. Clin Rev Allergy Immunol. 2020; 59(3):288–305.
https://doi.org/10.1007/s12016-020-08795-3
Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and other chronic childhood diseases. Br J Dermatol. 2006;155(1):145–151.
https://doi.org/10.1111/j.1365-2133.2006.07185.x
Chamlin SL, Frieden IJ, Williams ML, Chren MM. The effects of atopic dermatitis on young American children and their families: The Pediatric Dermato- logy Life Quality Index. Br J Dermatol. 2004;150(6): 1232–1238.
https://doi.org/10.1111/j.1365-2133.2004.05976.x
Cohen R, Ben-Amitai D, Zvulunov A. Atopic der- matitis in children: A comparative study of family impact and disease severity. Pediatr Dermatol. 2021;38(1):89–95.
https://doi.org/10.1111/pde.14405
Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10–19.
https://doi.org/10.1159/000245677
Lewis-Jones MS, Finlay AY. The Children’s Der- matology Life Quality Index (CDLQI): Initial vali- dation and practical use. Br J Dermatol. 1995;132(6): 942–949.
https://doi.org/10.1111/j.1365-2133.1995.tb16953.x
Holme SA, Man I, Sharpe JL, Dykes PJ, Finlay AY. The Children’s Dermatology Life Quality Index: Validation of the Urdu version and comparison with English. Br J Dermatol. 2003;149(2):397–401. https://doi.org/10.1046/j.1365-2133.2003.05418.x
Chernyshov PV. Quality of life measurement in atopic dermatitis in children. J Eur Acad Dermatol Venereol. 2020;34(6):1206–1215.
https://doi.org/10.1111/jdv.16336
Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F, et al. Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr. 2011;37:59.
https://doi.org/10.1186/1824-7288-37-59
Li L, Han Z, Niu X, Liu C, Zhang Y, Sun L, et al. Quality of life among children with atopic derma- titis in China: A cross-sectional study. Health Qual Life Outcomes. 2020;18(1):315.
https://doi.org/10.1186/s12955-020-01550-x
Kouassi YI, Ahogo KC, Bih OF, Kassi K, Menin OB, Kouassi BM, et al. Impact of atopic dermatitis on quality of life of children in Abidjan, Côte d’Ivoire. J Port Soc Dermatol Venereol. 2021;79(1):33–36.
https://doi.org/10.29021/spdv.79.1.1324
Javed M, Riaz H, Lodhi FS, Riaz I, Mujahid M, Naz M, et al. Socioeconomic status and quality of life in Pakistani children with atopic dermatitis: A multi- center study. Pak J Med Sci. 2023;39(2):403–409.
https://doi.org/10.12669/pjms.39.2.6936
Ahmed N, Chaudhry A, Tahir M, Toor SZ, Shafi- que A, et al. A comparative study on effect of endogenous and exogenous eczema on quality of life. Pak Armed Forces Med J. 2019;69(6):1330–1334. https://www.pafmj.org/index.php/PAFMJ/article/view/4510
Dey VK, Sharma V, Tripathi P, Singh S. Impact of atopic dermatitis on quality of life in children: A hospital-based study from eastern India. Indian J Dermatol. 2021;66(5):529–534.
https://doi.org/10.4103/ijd.IJD_367_20
Al-Zolibani AA, Al-Robaee AA, Al-Shobaili HA. Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J. 2011;32(11):1165–1169. https://doi.org/10.15537/smj.2011.11.10889
Egeberg A, Andersen YM, Thyssen JP. Quality of life and disease burden in atopic dermatitis. Curr Dermatol Rep. 2020;9(2):65–72.
https://doi.org/10.1007/s13671-020-00293-2
Egeberg A, Anderson P, Piercy J, Massey L, Cappelleri JC, Encinas GA, et al. Symptom burden of patients with moderate-to-severe atopic derma- titis. Eur J Dermatol. 2021;31(6):752–758.
https://doi.org/10.1684/ejd.2021.4166
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Pakistan Association of Dermatologists

This work is licensed under a Creative Commons Attribution 4.0 International License.